Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production

Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production

Numerous cell-based therapeutics are currently being tested in clinical trials. Human platelet lysate (HPL) is a valuable alternative to fetal bovine serum as a cell culture medium supplement for a variety of different cell types. HPL as a raw material permits animal serum-free cell propagation with...

Full description

Bibliographic Details
Main Authors: Michaela Oeller, Sandra Laner-Plamberger, Linda Krisch, Eva Rohde, Dirk Strunk, Katharina Schallmoser
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
regeneration
human platelet lysate (HPL)
good manufacturing practice (GMP)
cell therapy
platelet concentrates
regenerative medicine
Online Access:https://www.mdpi.com/1422-0067/22/10/5178

Internet

https://www.mdpi.com/1422-0067/22/10/5178

Similar Items